Healthcare · Diagnostics Research · NYSE
| Market cap | $243.49B |
|---|---|
| Trailing P/E | 27.6 |
| FCF yield | 2.5% |
| Revenue growth (YoY) | +3.9% |
| EPS growth (YoY) | +4.6% |
| FCF/share growth (YoY) | -12.3% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics Research |
Thermo Fisher Scientific Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Michael Rulli | House | Sell | $1,001 - $15,000 | Aug 7, 2026 |
| Alan Armstrong | Senate | Buy | $1,001 - $15,000 | Jul 21, 2026 |
| Alan Armstrong | Senate | Buy | $1,001 - $15,000 | Jul 21, 2026 |
| Dan Newhouse | House | Sell | $1,001 - $15,000 | Jul 17, 2026 |
| Dwight Evans | House | Sell | $1,001 - $15,000 | May 15, 2026 |
| Julia Letlow | House | Buy | $1,001 - $15,000 | Jan 13, 2026 |
| Julia Letlow | House | Sell | $1,001 - $15,000 | Jan 13, 2026 |
| Julia Letlow | House | Buy | $1,001 - $15,000 | Jan 13, 2026 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Nov 21, 2025 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Nov 21, 2025 |
| Valerie Hoyle | House | Sell | $1,001 - $15,000 | Oct 10, 2025 |
| Valerie Hoyle | House | Buy | $1,001 - $15,000 | Sep 12, 2025 |